TAS6417, a novel epidermal growth factor receptor inhibitor targeting exon 20 insertion mutations.
| Image |  |
|---|---|
| Description | scientific article |
| Author/s |
author: Renu Wadhwa |
| Publication date | May 10, 2018 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |